Performance, transparency, trust

We’re proud of the value we create for all our stakeholders, and strive to communicate our performance in a clear and timely manner. Download the latest reports, or stay up to date on various metrics of our market performance here. If you have any queries not addressed here, please feel free to get in touch with Investor Relations on our Contact page. 

Investors

Observe Medical ASA was listed on Oslo Børs 4 November 2019. Our ambition is to provide shareholders, analysts and investors simultaneous access to accurate, clear and relevant information. We aim to make all our communication to the financial market available on this web site. 

Read our latest regulatory news

Observe Medical ASA: Mandatory notification of trades by primary insider

(Oslo, 20 July 2020)  Notice of exercise of employee share options In connection with the expiry date at 31 March 2020, postponed by the Board of Directors to no later than 30 September 2020, Kathrine Gamborg Andreassen, board member, have at 20 July 2020 given notice that she will exercise a total of 125,000 options…

Read more

Observe Medical ASA – Registration of share capital increase

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…

Read more

Observe Medical ASA – Primary insider notice

Reference is made to Observe Medical ASA's (the "Company") stock exchange announcement on 6 July 2020 regarding the final result in the in the rights issue of 4,090,909 new shares in the Company (the "Offer Shares") at a subscription price of NOK 11.00 per share (the "Rights Issue"). Navamedic ASA ("NAVA"), represented at the Company's…

Read more

Financial calendar

  • 30.4.20

    Annual Report

  • 12.05.20

    Quarterly Presentation – Q1

  • 30.06.20

    Annual General Meeting

  • 18.08.20

    Half-yearly Report

  • 03.11.20

    Quarterly Presentation – Q3

The Share

Share performance

Shareholders

Last updated 3 August 2020

NameNumber of shares% of top 20% of totalCountry
1NAVAMEDIC ASA 4,222,727  26.02%21.73%Norway
2INGERØ REITEN INV. COMPANY AS 3,939,394  24.28%20.27%Norway
3RO, LARS 1,450,000  8.94% 7.46%NORWAY
4UBS SWITZERLAND AG 1,420,522 8.75% 7.31%SWITZERLAND
5ARTAL AS 858,951 5.29% 4.42%Norway
6ALPINE CAPITAL AS 645,000 3.97% 3.32%Norway
7NORDA ASA 516,570  3.18% 2.66%Norway
8TRANBERGKOLLEN INVEST AS 500,000  3.08% 2.57%Norway
9LEIKERANE AS 466,666  2.88% 2.40%Norway
10SOLEGLAD INVEST AS 461,668 2.85% 2.38%Norway
11LAPAS AS 336,924 2.08% 1.73%Norway
12MP PENSJON PK 262,025  1.61% 1.35%NORWAY
13KRAEBER VERWALTUNG GMBH 214,850 1.32% 1.11%GERMANY
14VICAMA AS 201,266 1.24% 1.04%Norway
15BUKKEVIK INVESTERING AS 140,000 0.86% 0.72%SWEDEN
16GINNY INVEST AS 128,894 0.79% 0.66%Norway
17BJØRNTVEDT, EIVIND 124,153 0.77% 0.64%Norway
18BJØRNTVEDT, VEGARD 119,358 0.74% 0.61%Norway
19NORDNET BANK AB 113,549 0.70% 0.58%Norway
20EILERAAS, KARL ANSGAR 104,491 0.64% 0.54%Norway
Total numBer owned by top 2016,227,098100.00%83.50%
Total number of shares19,433,582

Basic share data

Stock Exchange:

Ticker:

First day of listing:

Sector:

Trading Currency:

ISIN:

Number of shares issued:

Nominal value:

Oslo Axess

OBSERV

4 November 2019

Healthcare

NOK

NO0010865009

15 342 673

NOK 0.26

 

Nomination committee

The Articles of Association provide for a nomination committee composed of two or three members. The current members of the nomination committee are Bernt Olav Røttingsnes (chair) and Grete Hogstad.

The nomination committee is responsible for nominating candidates for the election of shareholder-elected members and chairperson to the Board of Directors and for nominating members to the nomination committee, as well as making recommendations for remuneration of these. 

For nomination committee please contact: 

Björn Larsson, Chief Executive Officer
+46 766 201 725 / bjorn.larsson@observemedical.com

 

IR contact

Björn Larsson, Chief Executive Officer
+46 766 201 725 / bjorn.larsson@observemedical.com

Per Arne Nygård, Chief Financial Officer
+47 41 10 43 45 / perarne.nygard@observemedical.com

Sign up for the mailing list